Anesthetic management of a ventilator-dependent parturient with the King-Denborough syndrome

Canadian Journal of Anesthesia

Volumn 50, Issue 6, 2003, Pages 589-592

  Habib, Ashraf S ^a   Millar, Simon ^a   Deballi III, Peter ^a   Muir, Holly A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; DANTROLENE; EPHEDRINE; ERGOT ALKALOID; FENTANYL; HYPERTENSIVE AGENT; LOCAL ANESTHETIC AGENT; OXYTOCIN; ROPIVACAINE; SUXAMETHONIUM;

ADULT; ANESTHESIA INDUCTION; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; CONGENITAL MALFORMATION; DISEASE PREDISPOSITION; DROWSINESS; EPIDURAL ANESTHESIA; FACE MALFORMATION; FEMALE; FORCEPS DELIVERY; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; KING DENBOROUGH SYNDROME; LABOR INDUCTION; MALIGNANT HYPERTHERMIA; MUSCLE WEAKNESS; MYOPATHY; NERVOUSNESS; OBSTETRIC ANALGESIA; PATIENT CONTROLLED ANALGESIA; PATIENT MONITORING; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RESPIRATORY FAILURE; SAFETY; SKELETON MALFORMATION; SLURRED SPEECH; TRACHEOSTOMY; VERTIGO; VISUAL IMPAIRMENT;

EID: 0042424658     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03018646     Document Type: Article

References (20)

1. King JO, Denborough MA, Zapf PW. Inheritance of malignant hyperpyrexia. Lancet 1972; 1: 365-70.
2. McPherson EW, Taylor CA Jr. The King syndrome: malignant hyperthermia, myopathy, and multiple anomalies. Am J Med Genet 1981; 8: 159-65.
3. Graham GE, Silver K, Arlet V, Der Kaloustian VM. King syndrome: further clinical variability and review of the literature. Am J Med Genet 1998; 78: 254-9.
4. Stewart CR, Kahler SG, Gilchrist JM. Congenital myopathy with cleft palate and increased susceptibility to malignant hyperthermia: King syndrome? Pediatr Neurol 1988; 4: 371-4.
5. Chitayat D, Hodgkinson KA, Ginsburg O, Dimmick J, Watters GV. King syndrome: a genetically heterogenous phenotype due to congenital myopathies. Am J Med Genet 1992; 43: 954-6.
6. Kaplan AM, Bergeson PS, Gregg SA, Curless RG. Malignant hyperthermia associated with myopathy and normal muscle enzymes. J Pediatr 1977; 91: 431-4.
7. Heiman-Patterson TD, Rosenberg HR, Binning CP, Tahmoush AJ. King-Denborough syndrome: contracture testing and literature review. Pediatr Neurol 1986; 2: 175-7.
8. Manning CW, Prime FJ, Zorab PA. Pregnancy and scoliosis. Lancet 1967; 2: 792-5.
9. Siegler D, Zorab PA. Pregnancy in thoracic scoliosis. Br J Dis Chest 1981; 75: 367-70.
10. Sawicka EH, Spencer GT, Branthwaite MA. Management of respiratory failure complicating pregnancy in severe kyphoscoliosis: a new use for an old technique? Br J Dis Chest 1986; 80: 191-6.
11. Weissberg N, Shemesh O, Schwartz G, Brisk R, Eylath U, Abraham AS. The rise of serum creatinine levels during labor. Arch Gynecol Obstet 1991; 249: 33-7.
12. Lucy SJ. Anaesthesia for caesarean delivery of a malignant hyperthermia susceptible parturient. Can J Anaesth 1994; 41: 1220-6.
13. Johnson C. Pregnancy and malignant hyperthermia (Letter). J Clin Anesth 1992; 4: 173.
14. Pollock NA, Langton EE. Management of malignant hyperthermia susceptible parturients. Anaesth Intensive Care 1997; 25: 398-407.
15. Shime J, Gare D, Andrews J, Britt B. Dantrolene in pregnancy: lack of adverse effects on the fetus and newborn infant. Am J Obstet Gynecol 1988; 159: 831-4.
16. Weingarten AE, Korsh JI, Neuman GG, Stern SB. Postpartum uterine atony after intravenous dantrolene. Anesth Analg 1987; 66: 269-70.
17. Douglas MJ, McMorland GH. The anaesthetic management of the malignant hyperthermia susceptible parturient. Can Anaesth Soc J 1986; 33: 371-8.
18. Khalil SN, Williams JP, Bourke DL. Management of a malignant hyperthermia susceptible patient in labor with 2-chloroprocaine epidural anesthesia. Anesth Analg 1983; 62: 119-21.
19. MHAUS Professional Advisory Council adopts new policy statement on local anaesthetics. Communicator 1985; 3: 1.
20. Willatts SM. Malignant hyperthermia susceptibility. Management during pregnancy and labour. Anaesthesia 1979; 34: 41-6.